ReutersSanofi links with Regeneron in $2.2 billion cancer drug pushReutersFrench drugmaker Sanofi (SASY.PA) said on Tuesday it was committing up to $2.17 billion to a collaboration with its long-time partner Regeneron Pharmaceuticals (REGN.O) in the hot area of cancer immunotherapy. Sanofi will make an upfront payment of ...Sanofi, Regeneron in $2.17B immuno-oncology dealMarketWatchSanofi Joins Regeneron in $2.2 Billion Pact for Cancer TherapiesBloombergRegeneron and Sanofi Launch Major New Immuno-Oncology CollaborationPR Newswire (press release)New York Times -Stockhouseall 10 news articles »
Sanofi links with Regeneron in $2.2 billion cancer drug push
Rating: 4.5
Diposkan Oleh: Unknown
